Skip to main content
Premium Trial:

Request an Annual Quote

Quest Diagnostics Divests OralDNA Labs

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has sold substantially all of the assets of its OralDNA Labs business to Access Genetics for an undisclosed sum.

The business, which currently provides saliva-based testing from a facility in Tennessee, will be consolidated with Access Genetics' CLIA- and CAP-certified lab in Eden Prairie, Minn. Quest noted that Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals since 2008.

The divestiture is part of Quest's ongoing efforts to refocus on its core diagnostic information services business for physicians and hospitals. The firm's management discussed those efforts in great detail during the firm's first-ever Investor Day last month.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.